Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/10493

Coumarin: Target Organs and Levels of Evidence for TR-422

Toxicology and Carcinogenesis Studies of Coumarin (CASRN 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies)

Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Coumarin
91-64-5
Gavage
R: 0,25,400, M: 0,30,150 MG/KG/5 PER GROUP
International Research & Development Corp.

Levels of Evidence: None



Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Coumarin
91-64-5
06/23/1992 Gavage
R: 0,25,50,100; M: 0,50,100,200 MG/KG/60 & 70 PER GROUP RESPECTIVELY
American Biogenics Corp (Bioassay Systems)

Levels of Evidence

Male Rats: Some Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Kidney Tubular Cell: ADENOMA 1/49 2/50 2/51 1/50, STEP SECTIONS 0/49 4/50 5/51 4/50
Non-Neoplastic Lesions
  • LIVER: CYTOLOGIC ALTERATIONS; FIBROSIS; NECROSIS; BILE DUCT HYPERPLASIA
  • FORESTOMACH: ULCER
  • PARATHYROID GLAND: HYPERPLASIA
  • KIDNEY: INCREASED SEVERITY OF NEPHROPATHY
Female Rats: Equivocal Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Kidney Tubular Cell: ADENOMA 0/49 0/50 0/50 2/49, STEP SECTIONS 0/49 0/50 1/50 1/49
Non-Neoplastic Lesions
  • LIVER: FIBROSIS; NECROSIS; DEGENERATION; BILE DUCT HYPERPLASIA
  • FORESTOMACH: ULCER
  • KIDNEY: INCREASED SEVERITY OF NEPHROPATHY
Male Mice: Some Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Lung: ALVEOLAR/BRONCHIOLAR ADENOMA 14/50 8/50 14/50 24/51 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 1/50 2/50 1/51 COMBINED 14/50 9/50 15/50 25/51
May Have Been Related
  • Forestomach: SQUAMOUS CELL PAPILLOMA 2/50 8/50 2/50 0/51
Non-Neoplastic Lesions
  • LIVER: SYNCYTIAL ALTERATION; CENTRILOBULAR HYPERTROPHY; EOSINOPHILIC FOCUS
Female Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Lung: ALVEOLAR/BRONCHIOLAR ADENOMA 2/51 5/49 7/49 20/51 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/51 0/49 0/49 7/51 COMBINED 2/51 5/49 7/49 27/51
  • Liver: ADENOMA 8/50 26/49 29/51 12/50
May Have Been Related
  • Forestomach: SQUAMOUS CELL PAPILLOMA 1/52 5/50 2/51 2/51
Non-Neoplastic Lesions
  • LIVER: SYNCYTIAL ALTERATION; CENTRILOBULAR HYPERTROPHY; EOSINOPHILIC FOCUS